ImmunityBio Changes Auditors to PricewaterhouseCoopers
Ticker: IBRX · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1326110
| Field | Detail |
|---|---|
| Company | Immunitybio, Inc. (IBRX) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
Related Tickers: IBIO
TL;DR
IBIO swapped auditors to PwC, effective March 13th.
AI Summary
ImmunityBio, Inc. filed an 8-K on March 19, 2025, to report a change in its certifying accountant. The company has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm, effective March 13, 2025. This change follows the resignation of the previous auditor, BDO USA, LLP.
Why It Matters
A change in auditors can signal potential concerns about financial reporting or internal controls, or it could be a routine decision as a company grows.
Risk Assessment
Risk Level: medium — A change in auditors, especially without explicit reasons provided, can sometimes indicate underlying issues with financial reporting or internal controls.
Key Players & Entities
- ImmunityBio, Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — New Certifying Accountant
- BDO USA, LLP (company) — Former Certifying Accountant
- March 13, 2025 (date) — Effective date of change
- March 19, 2025 (date) — Filing date of 8-K
FAQ
Who is ImmunityBio, Inc.'s new independent registered public accounting firm?
ImmunityBio, Inc. has appointed PricewaterhouseCoopers LLP as its new independent registered public accounting firm.
When was the change in certifying accountant effective?
The change in certifying accountant was effective March 13, 2025.
Who was ImmunityBio, Inc.'s previous independent registered public accounting firm?
The previous independent registered public accounting firm for ImmunityBio, Inc. was BDO USA, LLP.
What is the filing date of this 8-K report?
This 8-K report was filed on March 19, 2025.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in the registrant's certifying accountant.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding ImmunityBio, Inc. (IBRX).